Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT<sub>1A</sub> Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile.

Publication

Citation
Sniecikowska J, Gluch-Lutwin M, Bucki A, Więckowska A, Siwek A, Jastrzebska-Wiesek M, Partyka A, Wilczyńska D, Pytka K, Latacz G, Przejczowska-Pomierny K, Wyska E, Wesołowska A, Pawłowski M, Newman-Tancredi A, Kolaczkowski M.: Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT<sub>1A</sub> Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile. J Med Chem, Volume 63 (19), 2020
Authors
Bucki A, Jastrzębska-Więsek M, Kolaczkowski M., Latacz G, Newman-Tancredi A, Partyka A, Pawłowski M, Przejczowska-Pomierny K, Pytka K, Siwek A, Sniecikowska J, Wesołowska A, Więckowska A, Wilczyńska D, Wyska E
Journal
J Med Chem
Year
2020
PubMed
32883072
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc